These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31711261)
1. Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemotherapy. Hsu CC; Liu KH; Chang PH; Chen PT; Hung CY; Hsueh SW; Yeh KY; Chen YY; Lu CH; Hung YS; Chou WC J Gastroenterol Hepatol; 2020 Oct; 35(10):1694-1703. PubMed ID: 31711261 [TBL] [Abstract][Full Text] [Related]
2. Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma. Vienot A; Beinse G; Louvet C; de Mestier L; Meurisse A; Fein F; Heyd B; Cleau D; d'Engremont C; Dupont-Gossart AC; Lakkis Z; Tournigand C; Bouché O; Rousseau B; Neuzillet C; Bonnetain F; Borg C; Vernerey D J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28383673 [TBL] [Abstract][Full Text] [Related]
3. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment. Kim SY; Yoon MJ; Park YI; Kim MJ; Nam BH; Park SR Gastric Cancer; 2018 May; 21(3):453-463. PubMed ID: 28828688 [TBL] [Abstract][Full Text] [Related]
4. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy. Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278 [TBL] [Abstract][Full Text] [Related]
5. A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy. Xue P; Zhu L; Wan Z; Huang W; Li N; Chen D; Hu J; Yang H; Wang L J Cancer Res Clin Oncol; 2015 Sep; 141(9):1653-60. PubMed ID: 25792009 [TBL] [Abstract][Full Text] [Related]
6. Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. Kou T; Kanai M; Yamamoto M; Xue P; Mori Y; Kudo Y; Kurita A; Uza N; Kodama Y; Asada M; Kawaguchi M; Masui T; Mizumoto M; Yazumi S; Matsumoto S; Takaori K; Morita S; Muto M; Uemoto S; Chiba T Int J Clin Oncol; 2016 Feb; 21(1):118-25. PubMed ID: 26123314 [TBL] [Abstract][Full Text] [Related]
7. Nomogram-based parameters to predict overall survival in a real-world advanced cancer population undergoing palliative care. Zhao W; He Z; Li Y; Jia H; Chen M; Gu X; Liu M; Zhang Z; Wu Z; Cheng W BMC Palliat Care; 2019 Jun; 18(1):47. PubMed ID: 31167668 [TBL] [Abstract][Full Text] [Related]
8. Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy. Huang PW; Chang CF; Hung CY; Hsueh SW; Chang PH; Yeh KY; Chen JS; Chen YY; Lu CH; Hung YS; Chou WC Cancer Med; 2019 Sep; 8(12):5554-5563. PubMed ID: 31385456 [TBL] [Abstract][Full Text] [Related]
9. Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer. Deng GC; Lv Y; Yan H; Sun DC; Qu TT; Pan YT; Han QL; Dai GH BMC Cancer; 2021 Nov; 21(1):1227. PubMed ID: 34781928 [TBL] [Abstract][Full Text] [Related]
10. Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. Fornaro L; Leone F; Vienot A; Casadei-Gardini A; Vivaldi C; Lièvre A; Lombardi P; De Luca E; Vernerey D; Sperti E; Musettini G; Satolli MA; Edeline J; Spadi R; Neuzillet C; Falcone A; Pasquini G; Clerico M; Passardi A; Buscaglia P; Meurisse A; Aglietta M; Brac C; Vasile E; Montagnani F Clin Colorectal Cancer; 2019 Dec; 18(4):e394-e401. PubMed ID: 31564556 [TBL] [Abstract][Full Text] [Related]
11. Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy. Sun Y; Hu J; Wang R; Du X; Zhang X; E J; Zheng S; Zhou Y; Mou R; Li X; Zhang H; Xu Y; Liao Y; Jiang W; Liu L; Wang R; Zhu J; Xie R Cancer Med; 2024 Jul; 13(13):e7453. PubMed ID: 38986683 [TBL] [Abstract][Full Text] [Related]
12. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy. Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis. Fernández Montes A; López López C; Argilés Martínez G; Páez López D; López Muñoz AM; García Paredes B; Gutiérrez Abad D; Castañón López C; Jiménez Fonseca P; Gallego Plazas J; López Doldán MC; Martínez de Castro E; Sánchez Cánovas M; Tobeña Puyal M; Llorente Ayala B; Juez Martel I; López Flores M; Carmona-Bayonas A Oncologist; 2019 Aug; 24(8):e687-e695. PubMed ID: 31147489 [TBL] [Abstract][Full Text] [Related]
14. External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line chemotherapy: A multi-institute experience in Taiwan. Yu SM; Lu CH; Liu KH; Chen PT; Chang PH; Hung CY; Hsueh SW; Yeh KY; Chen YY; Hung YS; Chou WC Pancreatology; 2020 Jan; 20(1):116-124. PubMed ID: 31711795 [TBL] [Abstract][Full Text] [Related]
15. Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations. Neuzillet C; Casadei Gardini A; Brieau B; Vivaldi C; Smolenschi C; Brandi G; Tougeron D; Filippi R; Vienot A; Silvestris N; Pointet AL; Lonardi S; Rousseau B; Scartozzi M; Dahan L; Aprile G; Boussaha T; Malka D; Crusz SM; Le Sourd S; Meurisse A; Lièvre A; Vernerey D; ; ; ; Eur J Cancer; 2019 Apr; 111():94-106. PubMed ID: 30826661 [TBL] [Abstract][Full Text] [Related]
16. [A prognostic nomogram for metastasized colorectal cancer patients treated with cetuximab]. Zhong LP; Li D; Zhu LZ; Fang XF; Xiao Q; Ding KF; Yuan Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):701-708. PubMed ID: 32683833 [No Abstract] [Full Text] [Related]
17. A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer. Wang W; Sun Z; Deng JY; Qi XL; Feng XY; Fang C; Ma XH; Wang ZN; Liang H; Xu HM; Zhou ZW Cancer Commun (Lond); 2018 May; 38(1):23. PubMed ID: 29764518 [TBL] [Abstract][Full Text] [Related]
18. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Qi Q; Zhuang L; Shen Y; Geng Y; Yu S; Chen H; Liu L; Meng Z; Wang P; Chen Z Cancer; 2016 Jul; 122(14):2158-67. PubMed ID: 27152949 [TBL] [Abstract][Full Text] [Related]
19. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival Analysis. Xu D; Zhang K; Li M; Neoptolemos JP; Wu J; Gao W; Wu P; Cai B; Yin J; Shi G; Lu Z; Jiang K; Miao Y World J Surg; 2020 Apr; 44(4):1260-1269. PubMed ID: 31900571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]